Mobile

A Randomized, Double-Blind Study to Compare the Efficacy of Treatment with Denosumab versus Alendronate Sodium in Postmenopausal Women with Low Bone Mineral Density

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-005081-37

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the effect of denosumab compared to treatment with alendronate sodium (ALN) on percent change from baseline in bone mineral density (BMD) at the total hip as measured by dual energy X-ray absorptiometry (DXA) at 12 months in postmenopausal women.

Critère d'inclusion

  • Postmenopausal osteoporosis /osteopenia

Liens